IMMX icon

Immix Biopharma (IMMX)

NASDAQ

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
Market closed

IMMX: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$1.34 - $8.97
$431.05M
0.16
52.96M
-
No

What is Immix Biopharma (IMMX)?

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

The Immix Biopharma (IMMX) stock price has been falling

The Immix Biopharma, Inc. Common Stock (IMMX) stock price today is , reflecting a NaN% move since the market opened. The company’s market capitalization stands at $431.05M, with a daily trading volume of shares. The previous closing price was .

Get started with Immix Biopharma (IMMX)

Ready to get started? Follow the steps below, or read our guide on how to buy Immix Biopharma stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy IMMX

Search for IMMX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy IMMX.

IMMX FAQs

IMMX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

IMMX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Immix Biopharma, Inc. Common Stock (IMMX) has traded between a low of $1.34 and a high of $8.97.

IMMX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Immix Biopharma? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
IMMX icon
IMMX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Immix Biopharma in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.